Search Results 1571-1580 of 19168 for Neutrophil

1. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1,000/mcL**;; Platelets ≥ 100,000/mcL*;; Total bilirubin ≤ 1.5 × institutional upper limit of normal (ULN), (< 3 × ULN in the ...

2. TheraSphere With and Without Durvalumab and Tremelimumab for HCC - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1.5 x 109/L 3. Platelet count ≥75 x 109/L 4. Measured or calculated creatinine clearance ≥45 mL/min as determined by ...

3. Arthritis Clinical Trials

   ... neutrophil cytoplasmic antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. . Mayo Clinic Footer. Request ...

4. Acute Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

   ... neutrophil cytoplasmic antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. A Study to Evaluate Clinical ...

5. Olaparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

   absolute neutrophil count ≥1,500/mcL;; leukocytes ≥3,000/mcL;; platelets ≥100,000/mcL;; hemoglobin ≥8 g/dL;; total bilirubin ≤1.5 x upper limit of normal ...

6. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study - Mayo Clinic

   - Leukocytes ≥ 3,000/uL (within 28 days prior to step 2 registration). - Absolute neutrophil count ≥ 1,500/uL (within 28 days prior to step 2 registration) ...

7. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

   Absolute neutrophil count < 1,000/mm^3 (1.0 × 10^9 /L);; Absolute lymphocyte count < 500/mm^3 (0.5 × 10^9 /L);; Platelets < 100,000/mm^3 (100 × 10^9 /L); ...

8. Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm3 (≥ 1.5 GI/L) without granulocyte colony-stimulating factor support within 2 weeks before screening laboratory ...

9. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

   Absolute neutrophil count < 1500/µL;; Absolute lymphocyte count < 500/µL. Participating Mayo Clinic locations. Study statuses change often. Please contact the ...

10. Granuloma annulare - Doctors and departments - Mayo Clinic

    ... Neutrophilic dermatoses. Show more areas of focus for Anagha Bangalore Kumar, M.B.B.S.. By Mayo Clinic Staff · Request an appointment · Diagnosis & treatment.